INTRODUCTION
In this Analysis, which utilizes data from Datamonitor's pioneering Breast Cancer Insight study, the principles of mammography screening, and
diagnostic and biological testing are explained and the relative merits and disadvantages of each are debated.
SCOPE OF THE REPORT
- Use of diagnostic investigations by physicians is investigated, using data from Datamonitor's Breast Cancer Insight survey
- Datamonitor asks whether physicians routinely test the HER-2 status of their breast cancer patients; physicians' responses are presented and
analyzed.
- Datamonitor explores the degree to which cost, effectiveness and availability were influencing the way in which HER-2 status is determined.
REPORT HIGHLIGHTS
An analysis of Datamonitor's Breast Cancer Insight survey results, which interviewed 580 leading breast cancer specialists across Europe, the US
and Japan, in 2002, provides insight into the attitudes about, and requirements for, formal screening procedures and diagnostic techniques.
KEY REASONS TO BUY THIS REPORT
- Plan new drug development to meet patient management requirements
- Explore the reasons, rational and emotional, behind cancer specialists' decisions
- Predict future trends and perception in the treatment of breast cancer patients
View Cart
